Claus Bachert, MD, Professor and Head of Clinics of the Department of Otorhinolaryngology at Ghent University, Principal Investigator Behind FDA Approval of Dupixent for Chronic Rhinosinusitis With Nasal Polyposis

Claus Bachert, MD, Professor and Head of Clinics of the Department of Otorhinolaryngology at Ghent University, Principal Investigator Behind FDA Approval of Dupixent for Chronic Rhinosinusitis With Nasal Polyposis

Aug 1, 2019 | Bachert, Claus MD Content, Investigator Content, News

Claus Bachert, M.D., was the principal investigator of the SINUS-24 and SINUS-52 phase 3 trials, the results of which led to the FDA approval of Dupixent for use with other medicines to treat chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults whose disease...

Pin It on Pinterest